Ionis Pharmaceuticals | IONS - Current Assets


Ionis Pharmaceuticals reported $2.52B in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Agios Pharmaceuticals USD 942.05M 91.06M Dec/2025
Alnylam Pharmaceuticals USD 4.05B 97.85M Dec/2025
Arrowhead Research USD 1.17B 223.75M Dec/2025
Astellas Pharma JPY 1.44T 72.43B Dec/2025
BioCryst Pharmaceuticals USD 355.68M 42.78M Sep/2025
BioMarin Pharmaceutical USD 3.95B 98.95M Dec/2025
Celltrion KRW 5.54T 291.68B Sep/2025
Cspc Pharmaceutical CNY 22.61B 721.94M Jun/2025
Deva Holding AS TRY 9.13B 1.61B Sep/2023
Divis Laboratories Ltd INR 98.43B 2.38B Sep/2025
Esperion Therapeutics USD 360.46M 17.87M Sep/2025
Exelixis USD 1.44B 41.03M Dec/2025
Halozyme Therapeutics USD 825.21M 503.54M Dec/2025
Ionis Pharmaceuticals USD 2.52B 58.16M Sep/2025
Kangmei Pharma CNY 7.03B 128.34M Sep/2025
Knight Therapeutics CAD 397.57M 36.96M Sep/2024
Laboratorios Farma EUR 509.33M 128.63M Dec/2023
Malin Corporation EUR 62.6M 26.7M Dec/2024
Medical Developments International AUD 35.54M 2.13M Jun/2025
Moderna USD 6.54B 54M Dec/2025
Nektar Therapeutics USD 281.36M 94.79M Sep/2025
Neuren Pharmaceuticals AUD 320.25M 79.08M Jun/2025
Neurocrine Biosciences USD 2.52B 364.3M Dec/2025
Novartis USD 28.2B 2.26B Sep/2025
Omeros USD 69.65M 26.53M Jun/2025
OPKO Health USD 627.13M 43.8M Sep/2025
Organigram Holdings CAD 284.9M 7.11M Sep/2025
Ovoca Bio EUR 4.96M 2.06M Jun/2022
Pfizer USD 46.92B 3.22B Sep/2025
Pharma Mar EUR 242.88M 6.52M Sep/2025
PTC Therapeutics USD 2.27B 266.14M Dec/2025
Qiagen NV USD 2B 535.87M Dec/2025
Regeneron Pharmaceuticals USD 18.02B 41.2M Dec/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Sarepta Therapeutics USD 2.72B 65.32M Sep/2025
Sartorius EUR 1.72B 449M Sep/2025
Sino Biopharmaceutical CNY 33.82B 9.13B Jun/2025
Tilray USD 688.63M 2.34M Mar/2025
Ultragenyx Pharmaceutical USD 643.21M 76.58M Sep/2025
Vertex Pharmaceuticals USD 11.2B 631.4M Dec/2025
Zz Pientze Pharmaceu CNY 10.7B 1.59B Sep/2025